Jordana Joy, Associate Editor

When audited after completing an education training on the delivery of laser treatments found that optometrists specializing in glaucoma were competent in providing pre- and post-treatment care.

According to Adam Alexander, OD, Miebo can make headway in establishing a need for precision medication when it comes to dry eye treatment.

The silicone hydrogel daily disposable lenses contain a blend of osmoprotectants, electrolytes, and moisturizers to provide stable vision and keep eyes comfortable for 16 hours.

The company currently has CooperVision and Bausch + Lomb contact lenses available for customers to order.

LGBTQ patients are more at risk for not receiving health care due to fear of discrimination.

Catch up on what happened in optometry during the week of June 3-June 7.

The solution, CAM360 AmnioGraft, is hydrated and shelf-stable without need for refrigeration.

Award winners will be announced at the NORA 2024 Conference from September 19-22 in Kissimmee, Florida.

The trial, in part of the ASTRO study, will evaluate the efficacy, safety, and tolerability of sterile ophthalmic ointment 0.5%.

One of the resources provided by the partnership is a Dry Eye Wheel, which provides mitigation, measurement, and management processes to inform the treatment of dry eye disease.

The biotechnology company is developing the first protein-based artificial retina for patients with retinitis pigmentosa and age-related macular degeneration.

The novel therapy for dry eye is a cross-linked hyaluronic acid derivative cleared by the FDA.

The pachymeter is the most lightweight handheld product of its kind on the market, according to the company.

Catch up on what happened in optometry during the week of May 27-May 31.

The company’s initiatives include involvement with the Global Myopia Awareness Coalition and discounting blue light screen protectors and its pediatric eye care program, among others.

The COAST and ShORe trials have a total of 1984 patients enrolled for the treatment of wet age-related macular degeneration.

MyopiaX is a non-invasive, light-based treatment that uses a virtual reality headset to deliver treatment while patients engage with digital content.

Catch up on what happened in optometry during the week of May 20-May 24.

The Tono-Vera Tonometer allows for automated IOP measurements and eliminates the need for a topical anesthetic.

Representatives from CooperVision and the International Agency for the Prevention of Blindness give a preview of what to expect at the "Universal Access to Glasses: Promoting Multisectoral Action" event at this year's World Health Assembly in Geneva, Switzerland.

Christina Schiller, OD, Blake Jarrard, OD, and Christopher Herring, OD, were this year’s recipients.

Reed, OD, will take on the acting president role for the next two months and will be instated as president during this year's Optometry's Meeting.

Nazlee Zebardast, MD, MSc, overviews her 2 presentations from ARVO 2024 that utilized polygenic risk scores to identify patients' genetic risk of developing low risk for different glaucoma subtypes.

South Dakota’s newest scope expansion bill, signed into law earlier this year, offers new opportunities for optometrists.

Michael Belin, MD, weighs the ABCD and Amsler-Krumeich classifications and proposes ABCD progression displays as an effective modern alternative.

Phase 3 trials continue to investigate the efficacy of EpiSmart, a new method of cross-linking that could be utilized in the treatment of keratoconus.

DF-003 is a first-in-class, oral, potent, highly selective alpha-kinase 1 (ALPK1), an inhibitor believed to be responsible for causing ROSAH syndrome.

The program allows practices to sign up for rebate deals and discounted services.

Kourtney Houser, MD, and Kendall Donaldson, MD, MS, give an overview of the important role topography and tomography play in catching keratoconus early in their patients.

Annual follow-ups for patients with keratoconus can help them become better candidates for cross-linking procedures, according to William Trattler, MD.